Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

ver descrição completa

Detalhes bibliográficos
Main Authors: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Formato: Artigo
Idioma:English
Publicado em: Taylor & Francis Group 2019-06-01
Colecção:CNS Oncology
Assuntos:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Acesso em linha:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Internet

https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Registos relacionados